Cargando…

Epidemiological and evolutionary consequences of different types of CRISPR-Cas systems

Bacteria have adaptive immunity against viruses (phages) in the form of CRISPR-Cas immune systems. Currently, 6 types of CRISPR-Cas systems are known and the molecular study of three of these has revealed important molecular differences. It is unknown if and how these molecular differences change th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chabas, Hélène, Müller, Viktor, Bonhoeffer, Sebastian, Regoes, Roland R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355216/ https://www.ncbi.nlm.nih.gov/pubmed/35881633 http://dx.doi.org/10.1371/journal.pcbi.1010329

Ejemplares similares

Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity
por: Landsberger, Mariann, et al.
Publicado: (2018)

Evolutionary consequences of delaying intervention for monkeypox
por: Johnson, Philip L F, et al.
Publicado: (2022)

Assessing the public health impact of tolerance-based therapies with mathematical models
por: Hozé, Nathanaël, et al.
Publicado: (2018)

On the Origin and Evolutionary Relationships of the Reverse Transcriptases Associated With Type III CRISPR-Cas Systems
por: Toro, Nicolás, et al.
Publicado: (2018)

Casposons – silent heroes of the CRISPR-Cas systems evolutionary history
por: Smaruj, Paulina, et al.
Publicado: (2023)

Application of different types of CRISPR/Cas-based systems in bacteria
por: Liu, Zhenquan, et al.
Publicado: (2020)

Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches
por: Bouman, Judith A., et al.
Publicado: (2021)

Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation
por: Takizawa, Hitoshi, et al.
Publicado: (2011)

Mechanistic and evolutionary insights into a type V-M CRISPR–Cas effector enzyme
por: Omura, Satoshi N., et al.
Publicado: (2023)

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing
por: Leibowitz, Mitchell L., et al.
Publicado: (2021)

Classification and evolution of type II CRISPR-Cas systems
por: Chylinski, Krzysztof, et al.
Publicado: (2014)

Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages
por: Zhang, Shuzhong, et al.
Publicado: (2020)

A CRISPR evolutionary arms race: structural insights into viral anti-CRISPR/Cas responses
por: Wang, Jiuyu, et al.
Publicado: (2016)

Epidemiological and evolutionary consequences of periodicity in treatment coverage
por: Walter, Alicia, et al.
Publicado: (2021)

Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System
por: Hoikkala, Ville, et al.
Publicado: (2021)

No evidence of inhibition of horizontal gene transfer by CRISPR–Cas on evolutionary timescales
por: Gophna, Uri, et al.
Publicado: (2015)

Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9
por: Tao, Pan, et al.
Publicado: (2018)

The evolutionary history and diagnostic utility of the CRISPR-Cas system within Salmonella enterica ssp. enterica
por: Pettengill, James B., et al.
Publicado: (2014)

The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
por: Chylinski, Krzysztof, et al.
Publicado: (2013)

Conserved motifs in the CRISPR leader sequence control spacer acquisition levels in Type I-D CRISPR-Cas systems
por: Kieper, Sebastian N, et al.
Publicado: (2019)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas system
por: Aviram, Naama, et al.
Publicado: (2022)

Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems
por: Karpov, Dmitry S., et al.
Publicado: (2022)

Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system
por: Gleditzsch, Daniel, et al.
Publicado: (2016)

Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types
por: Wu, Wen Y., et al.
Publicado: (2022)

Divergent methylation of CRISPR repeats and cas genes in a subtype I-D CRISPR-Cas-system
por: Scholz, Ingeborg, et al.
Publicado: (2019)

Harnessing Type I and Type III CRISPR-Cas systems for genome editing
por: Li, Yingjun, et al.
Publicado: (2016)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Drug Inducible CRISPR/Cas Systems
por: Zhang, Jingfang, et al.
Publicado: (2019)

Origins and evolution of CRISPR-Cas systems
por: Koonin, Eugene V., et al.
Publicado: (2019)

Therapeutic Applications of the CRISPR-Cas System
por: Kang, Kyungmin, et al.
Publicado: (2022)

Mechanisms regulating the CRISPR-Cas systems
por: Zakrzewska, Marta, et al.
Publicado: (2023)

Application of CRISPR Cas Systems for Biosensing
por: Liu, Chung Chiun, et al.
Publicado: (2023)

Cold Cas: reevaluating the occurrence of CRISPR/Cas systems in Mycobacteriaceae
por: Brenner, Evan, et al.
Publicado: (2023)

Investigating the Consequences of Interference between Multiple CD8(+) T Cell Escape Mutations in Early HIV Infection
por: Garcia, Victor, et al.
Publicado: (2016)

The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems
por: Huang, Fengtao, et al.
Publicado: (2021)

Editorial: The CRISPR/Cas System in Pathogen Resistance, Virulence, Diagnosis and Typing
por: Duan, Guangcai, et al.
Publicado: (2022)

Diversity of CRISPR-Cas type II-A systems in Streptococcus anginosus
por: Bauer, Richard, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_14jcjugo11lgftpbu29a2rper9